Clinical Reference Laboratory Acquires Confirm BioSciences
December 9, 2020
Clinical Reference Laboratory (CRL), a large privately held clinical testing laboratory, has acquired Confirm BioSciences, a San Diego–based provider of screening tools and consumer-facing testing products. The acquisition will have Confirm operate as a subsidiary and is intended to expand CRL's lab testing and R&D capabilities while leveraging Confirm's large retail/customer base and COVID-19 testing pipeline.
- Buyers
- Clinical Reference Laboratory (CRL)
- Targets
- Confirm BioSciences
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Curative Inc. Acquires KorvaLabs, Inc.
May 19, 2020
Healthcare Services
Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.
-
Labcorp Acquires Certain BioReference Health Laboratory Assets for $237.5M
March 28, 2024
Healthcare Services
Labcorp will acquire certain laboratory testing businesses and operating assets from Opko Health subsidiary BioReference Health for $237.5 million. The assets — which generate roughly $100 million in annual revenue — include patient service centers and select customer contracts across the U.S. (excluding New York and New Jersey); BioReference Health will retain its oncology and urology diagnostic businesses and full operations in New York and New Jersey. The transaction is expected to close in the second half of 2024, subject to customary conditions and regulatory approvals.
-
Discovery Life Sciences Acquires ReachBio Research Labs
April 11, 2023
Biotechnology
Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.
-
Bio-Rad Acquires Celsee, Inc.
April 9, 2020
Biotechnology
Bio-Rad Laboratories has acquired Celsee, Inc., a developer of instruments and consumables for single-cell isolation, detection and analysis. The acquisition expands Bio‑Rad’s capabilities in single-cell analysis and precision medicine; terms were not disclosed.
-
Charles River Laboratories Acquires Cellero
August 6, 2020
Biotechnology
Charles River Laboratories (CRL) completed the acquisition of Cellero, a provider of donor and patient apheresis services, GMP-grade biomaterials, and custom laboratory services, for approximately $38 million in cash. The purchase, from Ampersand Capital Partners, expands Charles River's capabilities and offerings in cell and gene therapy support services worldwide.
-
BioCheck, Inc. Acquires DRG International, Inc.
August 18, 2021
Medical Devices
BioCheck, Inc. has acquired DRG International, Inc., a manufacturer of clinical diagnostic ELISAs and the DRG:HYBRiD-XL automated analyzer. The deal combines BioCheck's chemiluminescent assay development and automation platform with DRG's R&D, manufacturing and global distribution network to accelerate development and global scale-up of advanced clinical and research diagnostic tests.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.